Viewing Study NCT02935205


Ignite Creation Date: 2025-12-25 @ 3:11 AM
Ignite Modification Date: 2026-02-28 @ 10:35 PM
Study NCT ID: NCT02935205
Status: UNKNOWN
Last Update Posted: 2023-11-29
First Post: 2016-10-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer
Sponsor: Mamta Parikh
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 949968
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View